2024 Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) Global Committee 1st listed author Yishan Ye Journal Blood Cancer J.
2024 Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMT Group Cellular Therapy & Immunobiology Working Party (CTIWP) Practice Harmonisation and Guidelines Committee 1st listed author Simona Pagliuca Journal Lancet Haematol.
2024 Peripheral blood stem cell versus bone marrow graft for patients ≥60 years undergoing reduced intensity conditioning haploidentical transplantation for acute myeloid leukemia in complete remission: An analysis of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Raynier Devillier Journal Am J Hematol.
2024 Posttransplant cyclophosphamide versus anti-thymocyte globulin versus combination for graft-versus-host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Group Acute Leukemia Working Party (ALWP) 1st listed author Abdul-Hamid Bazarbachi Journal Cancer.
2024 ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation? Group Transplant Complications Working Party (TCWP) 1st listed author Olaf Penack Journal Leukemia.
2024 Graft-versus-host-disease prophylaxis with ATG or PTCY in patients with lymphoproliferative disorders undergoing reduced intensity conditioning regimen HCT from one antigen mismatched unrelated donor Group Lymphoma Working Party (LWP) 1st listed author Annalisa Paviglianiti Journal Bone Marrow Transplant.
2024 Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight Johannes Schetelig Group Cellular Therapy & Immunobiology Working Party (CTIWP) Other society 1st listed author Johannes Schetelig Journal Front Immunol.
2024 Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC) Group Chronic Malignancies Working Party (CMWP) 1st listed author Christian Niederwieser Journal Bone Marrow Transplant.
2024 Outcomes of allogeneic haematopoietic cell transplantation for myelofibrosis in children and adolescents: the retrospective study of the EBMT Paediatric Diseases WP Group Paediatric Diseases Working Party (PDWP) 1st listed author Jacek Wachowiak Journal Bone Marrow Transplant.
2024 Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation Group Infectious Diseases Working Party (IDWP) 1st listed author Julien De Greef Journal J Infect.
2024 Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) Global Committee 1st listed author Yishan Ye Journal Am J Hematol.
2024 Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT Group Severe Aplastic Anaemia Working Party (SAAWP) 1st listed author Juan Montoro Journal Blood.